Command Palette

Search for a command to run...

ANG Lifesciences India Ltd.
34.13(-4.98%)
1W: +33.14%

Financials

Charts

YoY Net Sales
Operating Margin
EPS Growth

Pros & Cons

POSITIVES
  • Consistent revenue growth over the last three quarters, indicating strong demand in the manufacturing sector.
  • Improved profit margins in the latest quarter, showcasing operational efficiency and cost management.
  • Positive cash flow trends suggest robust financial health and potential for reinvestment.
NEGATIVES
  • Significant increase in raw material costs affecting profit margins compared to previous quarters.
  • Declining sales volume in certain product segments indicating potential market saturation.
  • Higher operational expenses observed, impacting overall profitability despite revenue growth.

Quarterly Results Data

FieldTrendSep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25
Revenue
33.2618.5537.8418.4132.8924.7316.8224.60
Expenses
36.1224.8840.3723.8434.5230.8421.3627.42
Operating Profit
-2.85-6.34-2.53-5.43-1.64-6.11-4.54-2.82
Other Income
0.22-0.030.191.280.35-0.270.650.09
Interest
2.292.513.842.082.1822.421.94
Depreciation
2.221.912.051.631.741.961.421.53
Profit Before Tax
-2.63-6.37-4.08-4.14-1.29-6.38-3.89-2.73
Tax
-0.31-0.44-0.43-1.070.80-1.19-1.83-0.72
Net Profit
-2.32-5.93-3.65-3.07-2.09-5.19-2.06-2.01
Eps in Rs
-1.74-4.52-2.75-2.35-1.53-3.98-1.56-1.52